Shkreli faces stock slide as arrest hits biotech fortune
Martin Shkreli, former chief of KaloBios and Turing Pharmaceuticals, has seen his market value plummet after his arrest on securities fraud charges. KaloBios shares halved to about 11.03, with Shkreli owning over 2 million shares. Retrophin stock also fell, adding about 2.3 million in losses, as the case unfolds.
MENTIONED IN THIS ARTICLE
Martin Shkreli
KaloBios Pharmaceuticals
Turing Pharmaceuticals
Biotech
KaloBios
KBIO
TD Ameri
Shkreli
S&p Capital IQ
Retrophin
Wall Street
Tilles
SigFig Investors Report: Katy and Delray Beach Worst Returns
SigFig tracking shows investors in Katy Texas and Delray Beach Florida posted the worst 12 month returns at 2 percent. Delray Beach ranks among the top ten wealthiest U.S. cities by income, according to the data.
MENTIONED IN THIS ARTICLE
U.S
SigFig
Katy
Texas
Delray Beach
Fla
Car retailer miss in Q3 amid weak same-store sales
The used car retailer posted a 0.8 percent drop in same-store vehicle sales in the third quarter, though overall sales rose 3.2 percent. BlackBerry reported a smaller-than-expected quarterly loss and a first sales gain in over two years. Darden Restaurants saw quarter sales edge higher as Olive Garden raised prices and diners spent a bit more per visit.
MENTIONED IN THIS ARTICLE
U.S
BlackBerry
Darden Restaurants
Olive Garden
Protecting a portfolio from a market sell-off
The Federal Reserve signals caution as rates rise and borrowing costs grow. Investors should bake economic realities into stock prices and consider protective puts as insurance, or diversify with international and value stocks, plus bonds and cash to stay in for the long term.
MENTIONED IN THIS ARTICLE
Federal Reserve
Fed
Credit Suisse
Shkreli resigns as Turing Pharma CEO after arrest
Martin Shkreli, the controversial drug executive, resigns as CEO of Turing Pharmaceuticals one day after federal charges in a securities fraud case. Interim CEO Ron Tilles will lead as Shkreli faces a Ponzi-like scheme accusation involving Retrophin and other firms. Shkreli had sparked outrage for Daraprim price hikes and defense of his actions amid ongoing legal proceedings.
MENTIONED IN THIS ARTICLE
Shkreli
Turing Pharma
Martin Shkreli
Turing Pharmaceuticals
Ron Tilles
Martin
Craig Stevens
Turing
Also Mentioned on This Page
America
USA
AAPL
FOMX
Sigfic
EMI
APL
Idra Schw
MAJOR
Djia
DOW Jones
S&p 500
Standard & Poor's
Russell Russell
NRG Energy
NRG
Chesapeke Energy
CHE
Chesapeake
Congress
Southwestern Energy
SWN
DRI
Consol Energy
CNX
Deutsche
Carnival
CCL
Williams Williams Companies
WME
Pioneer Pioneer Natural Resources
PXC
Royal Caribbean Cruises
RCL
Sou
Ensco
ESV
KMX
Transocean
Cimarex Energy
XEC
Oneok
OKE
Ryder Ryder
Vanguard
Vanguard InstPlus
Fidelity Contra
Grthama m
Vanguard Totints
Incamera m
Incbua m
PSOC
BardPath
Spdr Financial Xle
iShs Emerg Mkts Eem
iShare Japan
EWJ
Mkt
Vect Gold Miners
GDX
iShares Bus
Bankrate.com Commodities Commodities
Frankfurt
Hong Kong
Japan
Nikkei
London
Mexico City
Morningstar
Associated Press
Usatoday.com
MONEY
Investing
Matt
Matt Krantz
Mxkrantz
USA Today
Ed Up
Brooklyn
New York
Evan Greebel
Securities and Exchange Commission
Andrew Burton
Gftty Images
This is just the beginning! Our collection holds over 300 years of history, including rare newspapers, obituaries, marriage records, birth records, and so much more—most of which you won’t find anywhere else!